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Abstract 13 
Background: Platelet cells, or thrombocytes, have additional roles to haemostasis. Post-14 
burn injury, platelet counts drop to a nadir at day 2-5 then rise to a peak between days 10-15 
18. The nadir has previously been associated with mortality but there is currently no 16 
thorough investigation of its potential to predict sepsis in adults. The primary objective of this 17 
study is to assess whether platelet count can predict survival and sepsis in adults with 18 
severe burn injuries. Methods and Findings: A retrospective cohort analysis of platelet 19 
count and other blood parameters in 145 burn patients with a TBSA greater than 20%. 20 
AUROC analysis revealed that the platelet count and rBaux score together produce 21 
moderate discrimination for survival at less than 24 hours post-injury (AUROC = 0.848, 22 
95%CI 0.765-0.930). Platelet count at day 3 combined with TBSA has a modest association 23 
with sepsis (AUROC = 0.779, 95%CI 0.697-0.862). Multivariable Cox regression analysis 24 
revealed platelet peak was the strongest predictor of mortality. Conclusions: A reduced 25 
peak platelet count is a strong predictor of 50-day mortality. Platelet count nadir may have 26 
some association with sepsis.   27 
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Introduction 28 
Platelets are known traditionally for their essential roles in haemostasis and thrombosis. 29 
However, their non-haemostatic roles as sentinels of the innate immune system during 30 
infection and inflammation are becoming increasingly recognised[1–3]. Several large clinical 31 
studies conducted in intensive care units suggest that thrombocytopenia is predictive of 32 
mortality and multiple organ failure during sepsis[4–6]. However, in burn injury, the diagnosis 33 
of sepsis is often more difficult due to a profound systemic inflammatory response obscuring 34 
the classical signs and diagnostic criteria. Intriguingly, platelet counts post-burn injury tend to 35 
follow a distinct pattern; falling to a nadir at day 2-5, then rising to a peak value at day 10-18. 36 
This has been investigated within animal models, case reports[7–9], and a number of larger 37 
scale studies[10–12]. A number of these studies have compared platelet counts and 38 
mortality[10,11,13]. More recently, Marck et al. investigated platelet counts within a large 39 
heterogeneous group (N = 244) of adult and paediatric burns patients, where 80% of the 40 
cohort had burns covering less than 29% total body surface area (TBSA). They compared 41 
both the nadir and peak values with mortality[14].  Both the mean nadir and peak platelet 42 
counts were significantly lower in both septic and non-surviving patients with lower peak 43 
counts predicting 50 day mortality (p < 0.05). However, Marck et al had very few septic 44 
patients in their cohort; hence, there has not been a proportional hazards model applied to 45 
an adult dataset of burns patients to investigate platelet count and sepsis. 46 
In this retrospective study of 145 patients with severe burn injuries (≥20% TBSA) we 47 
investigate whether the classical pattern of post-burn platelet counts are able to predict 48 
outcomes. In addition, we also examine if other routinely measured haematological 49 
parameters are helpful to the clinician in their assessment of the patient.  50 
 4 
 
Materials and Methods 51 
Patient Cohort 52 
This retrospective cohort study was conducted from January 2007 to May 2015. All burn 53 
patients were screened for eligibility. Table 1 shows the inclusion and exclusion criteria for 54 
the study. Clinical data were collected from the electronic patient record (EPR) and UK 55 
International Burn Injury Database (IBID) including: age at injury; gender; body mass index 56 
(BMI); length of stay in total (LOS) and in intensive care episodes (LOS ICU); mechanism of 57 
injury; inhalation injury status and severity; TBSA%; sepsis and mortality. Each patient was 58 
assessed for the presence of sepsis through appraisal of the EPR, paper records and 59 
observation charts.  60 
Table 1. Inclusion and exclusion criteria. 61 
Routine Haematological and Pathology Measurements 62 
Routine haematological parameters were extracted from the EPR for 50 days post-burn 63 
injury. These included: platelet count; white blood cell counts including the differential of 64 
lymphocytes and neutrophils and C-Reactive protein (CRP). All cellular parameters were 65 
measured in the routine cellular pathology laboratories at Queen Elizabeth Hospital 66 
Birmingham (QEHB) using a Beckman Coulter UniCel DxH 800 Cellular Analysis System 67 
from 2010 - 2015, and with a Beckman Coulter LH750 from 2007-2010. Both analysers use 68 
impedance based analysis for platelets with similar accuracy and precision[15,16]. Quality 69 
control was ensured by regular measurement of internal and external quality control 70 
samples.  71 
Clinical Definitions 72 
The primary outcomes were in-hospital 50-day mortality and incidence of sepsis. Sepsis was 73 
defined as a patient meeting a score of 3 or more using the 2007 American Burn Association 74 
criteria plus a temporally relevant positive microbiological culture result, (±5 days from the 75 
ABA indicated sepsis)[17]. Severity of injury was reported using the revised-Baux (rBaux) 76 
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score, defined by Osler et al[18].  This was preferred over other mortality scoring systems 77 
such as the Abbreviated Burn Severity Index (ABSI) as previous diagnostic test accuracy 78 
studies show it has greater accuracy in predicting mortality in severe burns[19,20]. 79 
Thrombocytopenia was defined as a platelet count of less than 150x109/L, and 80 
thrombocytosis as a platelet count of greater than 400x109/L[21]. The neutrophil-lymphocyte 81 
ratio (NLR) and platelet-lymphocyte ratio (PLR) were also calculated from routine 82 
parameters. Inhalational injury was defined as the presence of carbonaceous deposits, 83 
erythema, oedema, bronchorrhea or obstruction observed with or without the aid of 84 
bronchoscopy. Severity of inhalational injury was divided into mild, moderate or severe: Mild 85 
was defined as minor/patchy areas of erythema and carbonaceous deposits in the proximal 86 
or distal bronchi; Moderate as erythema with carbonaceous deposits, bronchorrhea with or 87 
without compromise of the bronchi; and severe was defined as any of the following: strong 88 
inflammatory response with friability, copious carbonaceous deposits, bronchorrhea, or 89 
bronchial obstruction. 90 
The nadir platelet count was defined as the lowest value between days 2-5. The peak 91 
platelet count was the highest value observed between days 11-17. These values are based 92 
on previous figures from the literature and experimental models[7–12,14].  93 
Statistical Methods 94 
Variables were assessed for normality both graphically, using Q-Q plots, and quantitatively 95 
using the Shapiro-Wilk test. The non-normal data are described by a median value with the 96 
Inter Quartile Range (IQR). Normal (Gaussian) distributed data are represented with the 97 
means and 95% confidence intervals. The Chi-squared test was used to test for significance 98 
between categorical variables. For continuous non-Normally distributed variables the 99 
Kruskal–Wallis Rank Sum Test or Mann-Whitney U test (if only 2 groups) were used to test 100 
for significance. For Normal continuous variables, the one-way ANOVA or Student’s t-test (if 101 
only 2 groups) were implemented. All tests were two-tailed. Longitudinal modelling of 102 
haematological parameters by group (both survival and sepsis) was performed using linear 103 
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mixed models to account for the correlation structure imposed by the within-patient 104 
repeated-measures data. Graphs of model fitted values were produced with the shaded 105 
envelope denoting the 95% confidence intervals. The area under the receiver operator 106 
curves (AUROCs) for each parameter were calculated for days 0, 1, 3, 7, 14, 21 and 28 107 
post-burn injury using logistic regression models. These models were adjusted for 108 
confounding due to severity of injury through the inclusion of the rBaux score. The outcomes 109 
for this analysis were survival and sepsis. All haematological variables were studied. Time to 110 
event analysis was conducted using Cox Regression. These models were adjusted for peak 111 
thrombocyte count and rBaux score with univariate analyses also carried out for the nadir 112 
thrombocyte count. Significance was set at the p < 0.05 level. Analyses were performed 113 
using the R statistical package (R version 3.3.1)[22]. All graphs were produced using R with 114 
the ggplot2 package[23]. The demographics table (table 2) was created using the tableone 115 
package[24].  116 
Results 117 
Patient Demographics 118 
A total of 3,975 patients with burns were admitted to the Birmingham adult burns centre at 119 
QEHB between 2007 and 2015. After applying inclusion and exclusion criteria, a final study 120 
cohort of 145 patients remained (Figure 1). The final demographics of the cohort are 121 
displayed in table 2. There were a greater proportion of male patients (59.3%) and the most 122 
common mechanism of injury was flame. The average burn size was 30%, with a mean 123 
rBaux score of 87.74. Half of the patients had inhalation injuries with 61.1% of those being 124 
moderate to severe. The observed mortality rate for the cohort was 24.8% and 41.4% of 125 
patients experienced at least one episode of sepsis. Univariate analyses showed some 126 
significant associations between variables and the outcomes of sepsis and survival. As 127 
expected, survival was significantly lower in the sepsis group. The presence of inhalation 128 
injury and LOS were significantly different between septic and non-septic patients. For both 129 
 7 
 
sepsis and survival, significant differences were found in: TBSA, ABSI and rBaux scores, 130 
and ICU admission. 131 
 132 
Figure 1. Participant flowchart showing application of exclusion and inclusion criteria. 133 
 134 
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Table 2. Demographics of study participants. BMI=body mass index; TBSA=total body surface area; 135 
FT/DD=full thickness burn ABSI=abbreviated burn severity index; rBaux=revised baux score; 136 
ICU=intensive care unit. *Missing data is due to death or discharge at the time of platelet peak count. ns 137 
(not shown) p > 0.05, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Square brackets denote the IQR 138 
where the median value is displayed and round brackets denote the SD where the mean value is 139 
displayed.  140 
Platelet count trajectories stratified by mortality or sepsis 141 
The time course of platelet counts are shown in Figure 2 and depict a classical 142 
thrombocytopenic nadir which is between days 2-4 with a peak of thrombocytosis on days 143 
11-17. Analysis of when each patient’s individual platelet nadir occurs shows that, on 144 
average, the nadir occurs on day 3. 57 (39.3%). Patients had their lowest platelet count on 145 
day 2, and 41 (28.3%) had their lowest platelet count on day 3. Interestingly, high platelet 146 
counts continue until day 50 post-injury without any indication of decline. This may be 147 
artefact due to the decreased frequency of platelet count results at later time-points, where 148 
the number of observations range between 114 and 128 across days 2 to 4 and between 77 149 
and 99 across days 11 to 17. However, this difference is not discernible from Figure 2. 150 
 151 
Figure 2. The observed platelet counts for the total cohort of severe burns over 50 days of admission. A 152 
nadir at days 2-4 is observed and a peak at days 13-14. The platelet counts are tightly distributed at the 153 
nadir but there is wider variability in the data at the peak. Grey points show outlier values. 154 
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To help account for the variability between patients in their patterns of platelet count, which 155 
is observable in Figure 2, a linear mixed effects modelling framework was applied to the data 156 
which included random uncorrelated effects for patient and day. The output of which can be 157 
seen in Figure 3. 158 
 159 
Figure 3. Platelet counts over time of the cohort after application of the linear mixed effects model which 160 
helps to account for individual variability across the cohort. Shaded areas represent 95% confidence 161 
intervals. 162 
The platelet counts were subsequently stratified by mortality (Figure 4). Survivors, for the 163 
most part, displayed a much higher platelet count at the nadir with a significantly greater 164 
platelet count at all stages post-day 5. These survivors also exhibited a significantly higher 165 
peak of thrombocytosis at day 16 compared with non-survivors. The survivors were still in 166 
range of thrombocytosis even at 50-days post-injury. On average, non-survivors did not 167 
display thrombocytosis at any given moment within the 50 days post-injury.  168 
When stratifying the cohort by sepsis (Figure 5) the sepsis group reached lower platelet 169 
count values at the nadir with marginal overlapping of confidence intervals. Similarly, to the 170 
groups stratified by survival, patients with sepsis exhibit a significantly lower platelet count 171 
peak at 15-20 days post-injury.  172 
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 173 
Figure 4. Platelet count stratified by survival. Platelet counts stratified by survival show a significant 174 
difference between groups at the nadir and at the peak. 175 
 176 
 177 
Figure 5. Platelet count stratified by sepsis. Platelet counts stratified by sepsis show a borderline non-178 
significant difference at the nadir, but a significant difference at the peak.  179 
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Daily models 180 
Daily logistic regression models were conducted for the nadir (days 2-4) and peak (days 11-181 
17) to investigate the relationship of platelet count on survival and sepsis. Analyses were 182 
conducted firstly with platelet count alone as a predictor, then with rBaux score added to the 183 
model to adjust for burn injury burden.  184 
Table 3 shows the model outcomes for survival. Survival odds ratios are significant from day 185 
2 post-burn in the nadir period and during all of the peak platelet count period even when 186 
adjusted for rBaux score. 187 
Table 3. Daily odds ratios for survival from logistic regression analysis for days 2-4 (platelet count nadir) 188 
and days 11-17 (platelet count peak). 189 
The model for sepsis is shown in Table 4. At day 3 post-injury there is a significant result 190 
even after adjustment with rBaux score suggesting that on day 3 platelet count may have 191 
some relation, and hence prediction, for sepsis. There are also significant results in the peak 192 
platelet count range in the univariate analysis.  193 
Table 4. Daily odds ratios for sepsis from logistic regression analysis for days 2-4 (platelet count nadir) 194 
and days 11-17 (platelet count peak). 195 
Time to event analysis 196 
Using a time to event analysis (Cox regression) the patients were censored separately for 197 
survival and sepsis.  Table 5 shows the summarized results from this analysis.  198 
Table 5. Cox regression analysis summarized into a table. Two multivariable models are summarized for 199 
each outcome (survival and sepsis): rBaux (a value composed from age, TBSA and inhalation injury) and 200 
platelet count (peak or nadir) were included. rBaux was included to correct for severity of injury. 201 
Continuous variables where categorised arbitrarily to allow the analysis to occur, hence the values for 202 
hazard radio correspond to: rBaux (per 10 points), peak platelet count (per 50x109/L), nadir platelet count 203 
(per 50x109/L).  204 
Peak platelet count appears to be related to survival (HR=0.813 (95% CI 0.756-0.874)) but 205 
the nadir shows no significant relation (p=0.077). Neither the peak platelet count does not 206 
appear to be associated with the hazard of developing sepsis. However, TBSA does have an 207 
influence on the multivariable model (p<0.0001), with a 5 percentage point increase in TBSA 208 
corresponding to an 18% increase in the hazard of having sepsis. However, even when 209 
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adjusted for rBaux the nadir platelet count still shows some relation to sepsis (HR=0.750 210 
(95% CI 0.574-0.979).  211 
AUROC analysis 212 
Area under the receiver operator curve analysis revealed that the platelet count alone shows 213 
poor discriminatory power for survival post-burn injury (Day 0, AUROC=0.534, 95%CI 0.387-214 
0.68). However, when combined with the rBaux score there is moderate discriminatory 215 
power at less than 24 hours post-injury (AUROC=0.848, 95%CI 0.765-0.93). 216 
In contrast platelet counts throughout the time course had limited power to discriminate 217 
between septic and non–septic patients even when combined with the rBaux score (Day 0, 218 
AUROC=0.742, 95%CI 0.648-0.835). Interestingly, the predictive power appears stronger 219 
when combined with TBSA% rather than rBaux. On days 0, 3 and 14 the AUROC was 0.756 220 
(95%CI 0.662-0.85), 0.779 (95% CI 0.697-0.862) and 0.776 (95% CI 0.676,0.876) 221 
respectively showing poor to moderate discriminatory power for predicting sepsis.  222 
Other variables 223 
The graphical representation of the data for NLR, PLR, CRP, and white blood cell counts 224 
including neutrophils and lymphocyte counts did not indicate any differences between sepsis 225 
and survival groups (data not shown).  226 
Discussion 227 
In this single centre retrospective study of a relatively large cohort of patients with severe 228 
burns we have, first of all, re-affirmed the classical pattern of platelet counts post-burn injury. 229 
Thrombocytopenia usually occurs with a nadir between days 2 and 5 followed by a peak of 230 
thrombocytosis at around day 11-17[7–12]. This early thrombocytopenia could be caused by 231 
any number of mechanisms including: haemodilution by resuscitation fluids; platelet 232 
activation with subsequent peripheral consumption; or by depressed bone marrow 233 
production.  234 
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It is remarkably difficult to discern to what degree haemodilution affects platelet count post-235 
burn injury. It is possible there is some effect, however studies investigating fluid 236 
replacement and platelet count have shown that low platelet count persists after fluid therapy 237 
has been stopped[25,26].  238 
Hence, it is reasonable to suggest that platelets are being consumed within the burn wound 239 
as a result of destruction of the dermal vasculature and subsequent microthrombi formation. 240 
These microthrombi form by 24-48 hours and so this may coincide with the nadir[27,28]. It is 241 
also well documented that the permeability of surrounding vessels increases along with 242 
development of widespread vascular hyper-permeability, and this may lead to increased 243 
activation of platelets through interaction with tissue factor on the sub-endothelium and 244 
activated clotting factors, leading to subsequent aggregation and consumption. Activated 245 
platelets may interact with circulating neutrophils and monocytes, potentiating their ability to 246 
extravasate into the sites of injury and affecting the platelet peripheral count [1,3].  247 
Bone marrow suppression as an explanation is less likely. Hampson et al showed that 248 
neutrophil and immature granulocyte counts are elevated significantly within 24 hours of 249 
injury[29]. Hence, there is a response profile suggesting active bone marrow post-burn 250 
injury. Previous autopsy studies in severe burns support this assertion as thrombocytopenia 251 
has been shown to have no association with fewer bone marrow megakaryocytes[30].  252 
There are various other factors that may affect platelet count. Drugs such as heparin can 253 
cause a thrombocytopenia (Heparin Induced Thrombocytopenia (HIT)) but this is typically 254 
later than we have seen in our cohort of patients, starting 5-10 days after the use of heparin 255 
and hence is unlikely to contribute dramatically, if at all, to our observations[31]. 256 
Observations in published case reports have also suggested that in some patients 257 
piperacillin-tazobactam, a commonly prescribed antibiotic, can cause thrombocytopenia but 258 
these cases are very rare[32,33].  259 
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The peak in platelet count for burns patients may be explained by an elevation of circulating 260 
Thrombopoeitin (TPO) levels following a fall in overall platelet mass early post-injury. This 261 
would stimulate platelet production from the bone marrow and may explain the rebound 262 
thrombocytosis that is seen in our cohort. This may also be exacerbated by inflammatory 263 
cytokines (e.g IL-6) during the SIRS response post injury. 264 
In our cohort there is an statistically significant difference in the platelet counts between 265 
survivors and non-survivors in days 3-4 and indeed also in the peak platelet count, even 266 
when corrected for the severity of injury using the rBaux score (OR=0.187 (95% CI 1.11-267 
3.15) and OR=0.175 (95% CI 1.10-2.80) respectively) (Error! Reference source not 268 
found.). Indeed, this is also apparent from the Cox regression analysis (HR=0.813 (95% CI 269 
0.756-0.874)). From previous burns literature, platelet count does appear to have some 270 
relationship with mortality. Wang et al studied massive burns (>70% TBSA) in 102 adults, 271 
and found that severe thrombocytopenia (platelet count < 20x109/L) was an independent 272 
predictor of mortality (p < 0.05)[11]. However, this is quite a substantial thrombocytopenia 273 
and such a substantial drop in platelet count is not frequently observed. Guo et al have also 274 
demonstrated that a reduction in platelet count of greater than 65% from baseline is 275 
predictive of 30-day mortality in burns patients (p = 0.028)[10]. It may be possible that the 276 
bone marrow response to the initial platelet count drop is different in survivors and non-277 
survivors. This could be due to an enhanced inflammatory response in these individuals 278 
stimulating bone marrow activity. Hence, measurement of both TPO and IL-6 levels over 279 
time might also be very informative of the status of the megakaryocyte/platelet axis.  280 
There is also a distinct difference between peak platelet count in septic patients compared to 281 
non-septic in the daily model analysis on days 11-17, but this difference is only found on 282 
days 11 and 12 when combined with rBaux to help correct for disease burden. This is not 283 
apparent in the multivariable Cox regression analysis (p=0.445). The effect may be 284 
explained due to a reduced platelet lifespan. Pathogenic E.coli and S.aureus have been 285 
shown to induce apoptotic mechanisms in platelets, through the degradation of Bcl-xL an 286 
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essential mediator of survival in platelets[34]. In addition, peptidoglycan a major constituent 287 
of gram positive bacterial cell walls, has been shown to induce mitochondrial depolarisation 288 
and caspase 3 activation, leading to platelet apoptosis[35]. Hence there are numerous 289 
mechanisms to suggest a reduced platelet life span in sepsis that may explain the reduced 290 
platelet peak observed in septic patients. 291 
The platelet nadir also appears to have some association with sepsis. The Cox regression 292 
analysis shows significant values for platelet nadir with sepsis as the outcome (HR=0.750 293 
(95% CI 0.574-0.979)), though data from the daily models adjusted with rBaux suggests this 294 
effect is predominantly on day 3 (OR=0.58 (95% CI 0.39-0.85)). However, the AUROC data 295 
suggests that this is a poor to moderate predictor. The mechanisms behind this are largely 296 
unknown however as discussed earlier, platelets have an important role in immunity. A lower 297 
platelet count could lead to a compromised immune response to infection and increase 298 
susceptibility to sepsis[36,37]. This is more likely than the converse, primarily due to the 299 
early occurrence of the nadir; sepsis is more likely to develop later post-burn injury[38].  300 
Our data shows that both NLR and PLR values do not vary significantly across the time 301 
course between the sepsis and survival outcome groups studied. It was therefore not 302 
surprising that they showed poor discriminatory power for these outcomes as assessed by 303 
AUROC. This contrasts with the findings in the non-burn critical care literature for predicting 304 
mortality, sepsis and length of hospitalisation. In one prospective cohort study NLR was 305 
shown by multivariable Cox regression to predict in-hospital and 6-month mortality to a 306 
reasonable degree (HR=1.63 (1.110-2.415) and 1.58 (1.136-2.213) respectively)[39]. NLR 307 
has also been shown to predict mortality in septic patients admitted to critical care 308 
(HR=1.043 (1.012–1.083))[40]. PLR has been shown to be associated with mortality and 309 
length of stay in critically ill diabetic ketoacidosis patients[41]. This is perhaps another 310 
example of the differences in pathophysiology between burn injury and other critical illnesses 311 
and the importance of studying burn injury as a discrete entity. 312 
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The Beckman Coulter analysers used during this study also measure platelet counts by the 313 
Coulter principle (or impedance analysis). There have been reported difficulties with the 314 
measurement of platelet counts in burns patients through impedance. This is due to the 315 
formation of circulating microspherocytes from the uncontrolled destruction of red blood cells 316 
(RBC) during the initial insult of thermal injury[42,43]. It has been previously shown that 317 
these RBC derived fragments can potentially interfere with impedance counts as they tend 318 
towards the same size range as platelets[42]. This could therefore produce spuriously 319 
elevated results and affect the statistical analysis of platelet counts in this and other studies. 320 
However, we now feel that this is unlikely due to our recent data directly quantifying these 321 
fragments along with 3 different platelet counts (including impedance and fluorescence 322 
measurements) post-injury. The results suggest that this interference effect is only significant 323 
immediately at day 1 post-injury (Dinsdale et al, 2017. Manuscript submitted).  324 
Diagnosis of sepsis is challenging in patients with severe burn injury because the systemic 325 
inflammatory response can mask the classical diagnostic criteria. A limitation of this study, 326 
and the other retrospective studies in this area, is in accurately identifying the occurrence of 327 
sepsis using clinical criteria. In this study, we used the ABA 2007 Consensus sepsis trigger 328 
criteria as these are widely used and burns specific. In 2016, new definitions for sepsis and 329 
septic shock were developed and published by a task force from the Society for Critical Care 330 
Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)[44]. The 331 
task force recommends the use of the Sequential Organ Failure Assessment (SOFA) score 332 
in ICU patients and the quick-SOFA (qSOFA) score in ward based or emergency department 333 
patients. This criterion has not yet been applied in a burns population and warrants 334 
evaluation of its discriminatory performance in this setting before it can be applied to the 335 
evaluation of potential laboratory diagnostic markers.  336 
Many of the variables we have measured are quantitative laboratory based values and these 337 
values are measured less regularly towards the end of a patient’s hospital episode. This is 338 
demonstrated by the broader confidence intervals towards day 50 post-injury indicating 339 
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lower precision in the graphs of the model based fitted values. Additionally, there are no 340 
children included in our sample of adult major burns. This was to remove any confounding 341 
effects from different platelet kinetic responses, but a disadvantage is that the results may 342 
not be generalizable to the paediatric population. Inherently the study design is also 343 
problematic when determining causality. Considering this, it is important to highlight that we 344 
are establishing the discriminatory power of these haematological parameters and not 345 
whether there is a causal link to the outcome of interest.  346 
Conclusions 347 
In conclusion, we have confirmed the kinetics of platelet counts in a large adult cohort of 348 
severe burns. With the exclusion of small burns (<20% TBSA) and children, we have 349 
removed potential confounders from different kinetic profiles. Platelet count and rBaux score 350 
together produce moderate discriminatory power for survival at less than 24hrs post-injury. 351 
Additionally, the platelet count at the nadir combined with TBSA has a modest association 352 
with sepsis. It was peak platelet count that showed strong predictive power for mortality 353 
when in a multivariable model with TBSA, age, rBaux score in the Cox regression model.  354 
In concert with clinical variables and a larger biomarker panel, platelet count may have 355 
diagnostic utility and aid the earlier diagnosis of sepsis in patients with severe burns. It 356 
appears peak platelet count has an association with mortality, further investigation should 357 
focus on why this might be. Together, these findings with future work may highlight patients 358 
with a more significant systemic inflammatory response that need tailored care to prevent 359 
and monitor for sepsis. Investigation into the mechanism of these platelet kinetics would be 360 
valuable for the understanding of physiology following burn injury.   361 
  362 
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Tables 489 
Included Excluded  
 Aged 16-99 
 Total body surface area 
percentage (TBSA%) is greater 
than or equal to 20% 
 At least one platelet count within 
48 hours of injury 
 A minimum of 4 platelet counts 
within the first 7 days of admission  
 Non-acute burn injury 
 Diagnosed with platelet disorders. 
 Patients diagnosed with skin blistering 
conditions (such as TENS) 
 Chemical burn injury 
 Patients admitted for comfort care 
(where a decision is made within the first 
24 hours) 
 Incomplete data or unable to obtain 
medical notes 
Table 1. Inclusion and exclusion criteria. 490 
  491 
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Overall 
 Sepsis  Survival 
  Yes No   Yes No  
N 145  60 85   109 36  
Gender male (%) 86 (59.3)  31 (51.7) 55 (64.7)   66 (60.6) 20 (55.6)   
Age 39.00 [28.00, 
53.00] 
 39.00 [30.75, 
49.00] 
39.00 [28.00, 
54.00] 
  36.00 [28.00, 
47.00] 
49.00 [37.75, 
65.00]  
*** 
BMI  25.86 [22.00, 
28.65] 
 25.39 [22.49, 
28.41] 
26.12 [23.44, 
29.24] 
  25.39 [22.89, 
28.24] 
27.44 [24.01, 
29.39]  
 
Mechanism of 
injury (%) 
         
Contact 3 (2.1)  0 (0.0) 3 (3.5)  3 (2.8) 0 (0.0)   
Electrical 7 (4.8)  2 (3.3) 5 (5.9)   6 (5.5) 1 (2.8)   
Flame 109 (75.2)  50 (83.3) 59 (69.4)  77 (70.6) 32 (88.9)   
Flash 7 (4.8)  2 (3.3) 5 (5.9)  6 (5.5) 1 (2.8)   
Mixed 6 (4.1)  3 (5) 3 (3.5)   6 (5.5) 0 (0.0)   
Scald 
 
13 (9.0)  3 (5.0) 10 (11.8)   11 (10.1) 2 (5.6)   
TBSA 30.00 [23.00, 
48.50] 
 45.50 [30.00, 
59.25] 
25.00 [22.00, 
31.50] 
***  28.00 [22.00, 
43.00] 
45.50 [30.00, 
55.75]  
*** 
FT/DD%  15.00 [4.00, 
33.50] 
 24.75 [10.75, 
50.50] 
10.00 [2.00, 
23.50] 
***  10.00 [2.00, 
24.00] 
33.75 [20.19, 
50.50] 
*** 
ABSI  
 
 
8.00 [7.00, 
10.00] 
 10.00 [9.00, 
11.00] 
7.00 [6.00, 
9.00] 
***  8.00 [6.00, 
9.00] 
10.00 [9.00, 
11.00] 
*** 
rBaux score 87.74 (25.24)  100.33 
(23.22) 
78.85 
(22.81) 
***  80.72 
(22.94) 
108.99 
(19.51) 
*** 
Inhalation (%) 72 (49.7)  40 (66.7) 32 (37.6) ***  50 (45.9) 22 (61.1)   
Inhalation 
severity (%) 
         
Mild 28 (38.9)  11 (27.5) 17 (53.1)  24 (48.0) 4 (18.2)  
Moderate 25 (34.7)  15 (37.5) 10 (31.2)  15 (30.0) 10 (45.5)  
Severe 19 (26.4)  14 (35.0) 5 (15.6)  11 (22.0) 8 (36.4)  
Nadir platelet 
count (x 109 /L) 
114.00 [82.00, 
149.00] 
 96.50 [71.75, 
125.75] 
126.00 
[88.00, 164.00] 
**  122.00 
[88.00, 163.00] 
85.00 [68.50, 
99.50]  
*** 
Peak platelet 662.68  578.24 719.34 **  722.63 418.08 *** 
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count (x 109 /L) (283.11) (301.63) (256.71) (261.58) (235.02) 
LOS  34.00 [21.00, 
56.00] 
 45.50 [25.00, 
76.25] 
28.00 [19.00, 
44.00] 
**  39.00 [22.00, 
57.00] 
25.00 [11.75, 
35.50] 
** 
ICU admission 
(%) 
97 (66.9)  57 (95.0) 40 (47.1) ***  64 (58.7) 33 (91.7) *** 
ICU LOS 19.00 [7.50, 
30.00] 
 22.01 [9.25, 
34.75] 
17.00 [7.00, 
25.00] 
  22.01 [8.25, 
34.75] 
15.00 [7.00, 
25.00] 
 
Survived (%) 109 (75.2)  38 (63.3) 71 (83.5) *     
Septic (%) 60 (41.4)      38 (34.9) 22 (61.1)  * 
 492 
Table 2. Demographics of study participants. BMI=body mass index; TBSA=total body 493 
surface area; FT/DD=full thickness burn ABSI=abbreviated burn severity index; 494 
rBaux=revised baux score; ICU=intensive care unit. *Missing data is due to death or 495 
discharge at the time of platelet peak count. ns (not shown) p > 0.05, * p ≤ 0.05, ** p ≤ 0.01, 496 
*** p ≤ 0.001, **** p ≤ 0.0001. Square brackets denote the IQR where the median value is 497 
displayed and round brackets denote the SD where the mean value is displayed. 498 
  499 
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  Univariate Analysis  Adjusted for rBaux 
 Day Survival 
OR 
95% CI p-value  Survival 
OR 
95% CI p-
value 
Nadir 
2 1.28 (0.88, 1.88) 0.1999  1.25 (0.83, 1.89) 0.279 
3 2.20 (1.37, 3.52) 0.0010  1.87 (1.11, 3.15) 0.018 
4 2.21 (1.42, 3.45) 0.0005  1.75 (1.10, 2.80) 0.019 
Peak 
11 1.30 (1.11, 1.53) 0.0010  1.22 (1.04, 1.44) 0.018 
12 1.30 (1.13, 1.50) 0.0004  1.21 (1.04, 1.41) 0.016 
13 1.35 (1.16, 1.57) 0.0001  1.28 (1.08, 1.51) 0.004 
14 1.29 (1.12, 1.48) 0.0004  1.24 (1.07, 1.44) 0.005 
15 1.34 (1.14, 1.56) 0.0003  1.29 (1.08, 1.53) 0.004 
16 1.24 (1.09, 1.41) 0.0011  1.21 (1.05, 1.39) 0.008 
17 1.20 (1.06, 1.35) 0.0038  1.17 (1.02, 1.34) 0.030 
Table 3. Daily odds ratios for survival from logistic regression analysis for days 2-4 (platelet 500 
count nadir) and days 11-17 (platelet count peak).  501 
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  Univariate Analysis  Adjusted for rBaux 
 Day Sepsis 
OR 
95% CI p-value  Sepsis 
OR 
95% CI p-value 
Nadir 
2 0.83 (0.61, 1.13) 0.2428  0.86 (0.61, 1.19) 0.359 
3 0.52 (0.36, 0.75) 0.0005  0.58 (0.39, 0.85) 0.005 
4 0.71 (0.53, 0.95) 0.0230  0.88 (0.64, 1.20) 0.406 
Peak 
11 0.83 (0.74, 0.93) 0.0018  0.87 (0.77, 0.98) 0.024 
12 0.84 (0.75, 0.93) 0.0011  0.88 (0.79, 0.98) 0.025 
13 0.91 (0.84, 0.99) 0.0220  0.95 (0.87, 1.03) 0.211 
14 0.90 (0.82, 0.98) 0.0175  0.92 (0.84, 1.01) 0.081 
15 0.91 (0.84, 0.99) 0.0318  0.93 (0.86, 1.02) 0.113 
16 0.92 (0.85, 1.00) 0.0464  0.95 (0.87, 1.03) 0.190 
17 0.88 (0.81, 0.97) 0.0085  0.91 (0.82, 1.00) 0.059 
Table 4. Daily odds ratios for sepsis from logistic regression analysis for days 2-4 (platelet 502 
count nadir) and days 11-17 (platelet count peak).  503 
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  Hazard Ratio 95% CI p-value 
Survival 
Model 1 
rBaux 1.124 (0.963, 1.311) 0.137 
Peak platelet count 0.813 (0.756, 0.874) < 0.0001 
Model 2 
rBaux 1.251 (1.085, 1.442) 0.002 
Nadir platelet count 0.601 (0.410, 0.881) 0.077 
Sepsis 
Model 3 
rBaux 1.223 (1.094, 1.366) 0.0004 
Peak platelet count 0.983 (0.941, 1.027) 0.445 
Model 4 
rBaux 1.186 (1.066, 1.320) 0.002 
Nadir platelet count 0.750 (0.574, 0.979) 0.035 
Table 5. Cox regression analysis summarized into a table. Two multivariable models are 504 
summarized for each outcome (survival and sepsis): rBaux (a value composed from age, 505 
TBSA and inhalation injury) and platelet count (peak or nadir) were included. rBaux was 506 
included to correct for severity of injury. Continuous variables where categorised arbitrarily to 507 
allow the analysis to occur, hence the values for hazard radio correspond to: rBaux (per 10 508 
points), peak platelet count (per 50x109/L), nadir platelet count (per 50x109/L).   509 
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Legends for Illustrations 510 
Figure 1. Participant flowchart showing application of exclusion and inclusion criteria. 511 
REQUIRES COLOUR Figure 2. The observed platelet counts for the total cohort of severe 512 
burns over 50 days of admission. A nadir at days 2-4 is observed and a peak at days 13-14. 513 
The platelet counts are tightly distributed at the nadir but there is wider variability in the data 514 
at the peak. Grey points show outlier values. 515 
Figure 3. Platelet counts over time of the cohort after application of the linear mixed effects 516 
model which helps to account for individual variability across the cohort. Shaded areas 517 
represent 95% confidence intervals 518 
REQUIRES COLOUR Figure 4. Platelet count stratified by survival. Platelet counts stratified 519 
by survival show a significant difference between groups at the nadir and at the peak. 520 
REQUIRES COLOUR Figure 5. Platelet count stratified by sepsis. Platelet counts stratified 521 
by sepsis show a borderline non-significant difference at the nadir, but a significant 522 
difference at the peak. 523 
